Biliary complications after living donor liver transplantation: analysis of risk factors and outcomes in 820 recipients

نویسندگان

چکیده

Presenter: Kausa Makki MBBS, MS | Fortis Hospitals Background: Biliary complications (BC) after LDLT continues to be an important cause of morbidity, graft loss, and mortality. Study aims identify risk factors, analyse clinical presentations outcome patients with BC, evaluate impact BC on survival. Methods: Retrospective analysis 820 primary LDLTs performed at our institute between December 2011 2018. With a median follow-up 34 months (range: 1 month-95 months), the overall incidence was 6.7% (n = 55). Patients without (group A, n 765) B, 55) were compared. Results: Male recipient gender (p 0.034) sarcopenia (p-value 0.00) statistically significant factors for both univariate multivariate analysis. Thirty-two (58.2%) presented biliary stricture 23 (42.8%) leak with/without stricture. Overall, 1, 3, 5-year patient survival significantly inferior in (82.3%, 76.9%, 72.1%) compared those (92.8%, 90.8%, 90.1%). Conclusion: Sarcopenia is determinant BCs LDLT. remains loss. Management strategies need tailored based presentation available expertise centre.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation.

BACKGROUND Although data about the incidence and management of biliary complications after deceased-donor liver transplantation (DDLT) are well defined, those pertaining to adult living-donor liver transplantation (LDLT) are conflicting. METHODS We retrospectively compared endoscopic retrograde cholangio-pancreatography (ERCP) findings in 30 LDLT vs. 357 DDLT consecutive adult recipients with...

متن کامل

Living donor liver transplantation for biliary atresia.

Biliary atresia is the most common cause of chronic cholestasis in infants and children. The incidence is estimated at 3.7:10,000 among Taiwanese infants. Kasai hepatoportoenterostomy helps children survive beyond infancy. Liver transplantation is indicated when the Kasai procedure fails to work or when patients develop progressive deterioration of liver function despite an initially successful...

متن کامل

Biliary Complications after Liver Transplantation

BACKGROUND Biliary reconstitution has been considered the Achilles's heel of liver transplantations due to its high rate of postoperative complications. AIM To evaluate the risk factors for occurrence of biliary strictures and leakages, and the most efficient methods for their treatment. METHOD Of 310 patients who underwent liver transplantation between 2001 and 2015, 182 medical records we...

متن کامل

Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.

In this retrospective study of hepatitis C virus (HCV)-infected transplant recipients in the 9-center Adult to Adult Living Donor Liver Transplantation Cohort Study, graft and patient survival and the development of advanced fibrosis were compared among 181 living donor liver transplant (LDLT) recipients and 94 deceased donor liver transplant (DDLT) recipients. Overall 3-year graft and patient ...

متن کامل

Risk factors and treatments for hepatic arterial complications in pediatric living donor liver transplantation.

BACKGROUND Hepatic artery complications (HAC) are a serious complication in pediatric liver transplant recipients because its incidence is high and it can occasionally lead to graft liver failure. We herein present a retrospective analysis of our 10-year experience with pediatric living donor liver transplantation (LDLT) focusing on the risk factors and treatments for HAC. METHODS Between May...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Hpb

سال: 2021

ISSN: ['1365-182X', '1477-2574']

DOI: https://doi.org/10.1016/j.hpb.2021.06.064